Histological assessment of the mammary glands injected with MT/ShcA+/+ breast cancer cells and their corresponding STAT1- or STAT3-deficient counterparts revealed the presence of microscopic lesions in ∼40% of the mammary glands at necropsy (Supplementary Fig. 8a). This evidence concerns the gene STAT3 and breast cancer.